DC Circ. Asked To Freeze DOJ's Medical Pot Rescheduling
A trade association for drug-testing companies and a biopharma firm developing marijuana-derived drugs have urged the D.C. Circuit to hit pause on a U.S. Department of Justice rule rescheduling state-sanctioned medical...To view the full article, register now.
Already a subscriber? Click here to view full article